UN

Uncommon Therapeutics

YC W25

San Francisco, US · Founded 2024 · 2 employees · 1 known investors

uncommontherapeutics.com ↗

Uncommon Therapeutics uses advanced technologies to develop drugs targeting rare genetic diseases, starting with Rett Syndrome, a neurodevelopmental disorder affecting approximately 1 in 10,000 girls. The company combines disease expertise with efficient drug development to advance therapeutics from discovery to clinical application.

Founders & leadership· Y Combinator alumni (W25)

Noah AuerhahninFounder

Ryan LiminFounder

Investors · 1

Y

Y CombinatorMountain View · $500K – $500K